Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed COO
Appointed director
|
|
BridgeBio Pharma, Inc. (BBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,301 shares
@ $29.8, valued at
$38.8k
Exercised 3,760 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 50,698 shares
@ $29.8, valued at
$1.5M
Sold 51,552 shares
@ $28.5883, valued at
$1.5M
Exercised 5,130 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0
Exercised 33,544 restricted stock units
@ $0 |
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 50,697 shares
@ $14.09, valued at
$714.3k
Sold 51,552 shares
@ $14.0095, valued at
$722.2k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0
Exercised 33,544 restricted stock units
@ $0 |
|
| 05/18/2023 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,300 shares
@ $14.09, valued at
$18.3k
Exercised 3,759 restricted stock units
@ $0 |
|
| 05/18/2023 |
4
| STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 20,572 shares
@ $14.09, valued at
$289.9k
Sold 24,424 shares
@ $14.0095, valued at
$342.2k
Exercised 1,710 restricted stock units
@ $0
Exercised 778 restricted stock units
@ $0
Exercised 24,193 restricted stock units
@ $0
Exercised 947 restricted stock units
@ $0
Exercised 17,368 restricted stock units
@ $0 |
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2023 |
4
| STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 62,692 shares
@ $10.9607, valued at
$687.1k
|
|
| 03/03/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 120,000 shares
@ $10.9602, valued at
$1.3M
|
|
| 02/28/2023 |
3
| MCCORMICK FRANK (Director) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 02/23/2023 |
4
| MCCORMICK FRANK (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 158,814 options to buy
@ $11.92, valued at
$1.9M
|
|
| 02/21/2023 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,304 shares
@ $12.64, valued at
$16.5k
Exercised 3,196 restricted stock units
@ $0 |
|
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,534 shares
@ $12.64, valued at
$19.4k
Exercised 3,760 restricted stock units
@ $0 |
|
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 23,908 shares
@ $12.64, valued at
$302.2k
Sold 44,798 shares
@ $12.7031, valued at
$569.1k
Exercised 5,129 restricted stock units
@ $0
Exercised 2,395 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 323,431 options to buy
@ $11.41, valued at
$3.7M
Granted 277,893 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 624,652 options to buy
@ $11.41, valued at
$7.1M
Granted 536,704 restricted stock units
@ $0 |
|
| 02/06/2023 |
4
| STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 61,040 shares
@ $11.0079, valued at
$671.9k
|
|
| 02/06/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 120,000 shares
@ $11.0058, valued at
$1.3M
|
|
| 01/06/2023 |
4
| STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 61,040 shares
@ $7.6748, valued at
$468.5k
|
|
| 01/06/2023 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 120,000 shares
@ $7.6738, valued at
$920.9k
|
|
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 34,066 shares
@ $9.64, valued at
$328.4k
Sold 34,640 shares
@ $9.3997, valued at
$325.6k
Exercised 5,130 restricted stock units
@ $0
Exercised 2,394 restricted stock units
@ $0
Exercised 61,182 restricted stock units
@ $0 |
|
| 11/18/2022 |
4
| STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 10,789 shares
@ $9.64, valued at
$104k
Sold 19,678 shares
@ $9.4006, valued at
$185k
Exercised 1,710 restricted stock units
@ $0
Exercised 778 restricted stock units
@ $0
Exercised 24,193 restricted stock units
@ $0
Exercised 3,786 restricted stock units
@ $0 |
|
| 11/18/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,106 shares
@ $9.64, valued at
$10.7k
Exercised 3,196 restricted stock units
@ $0 |
|
| 11/18/2022 |
4
| HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,301 shares
@ $9.64, valued at
$12.5k
Exercised 3,760 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 9,227 shares
@ $11.08, valued at
$102.2k
Exercised 1,709 restricted stock units
@ $0
Exercised 778 restricted stock units
@ $0
Exercised 24,193 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Valantine Hannah (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 104,921 options to buy
@ $8.45, valued at
$886.6k
|
|
|
|
|